Warning letters, 483s, Recalls, Import Alerts, Audit observations
Piramal Pharma’s API unit at Navi Mumbai (FEI 3008763768) was issued USFDA Form 483 with
Janssen’s Korean Vaccine unit Janssen Vaccines Corporation (FEI 3012637764) received an USFDA 483 for critical
Indoco Remedies’ Goa Plant received a warning letter from the FDA following critical observations during
Sun Pharma Dadra unit was inspected by USFDA in December 2023 by FDA investigator Pratik
The USFDA 483 issued to Sun Pharma, Dadra unit in India (FEI 3004561553) published by
USFDA 483 to Intas cites lapses in investigation and review of failures and discrepancies in
USFDA 483 to Lupin Pithampur in Mar 2023 (Inspectors Eileen A Liu, Yvins Dezan) cites
USFDA inspection of Cipla Pithampur site ( FEI 3008581988) by Inspectors Saleem A Akhtar &Â
USFDA issues Warning letter to DuPont Nutrition USA Inc., Newark, Delaware facility (FEI 3013947845) for
